MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bcr-2022-251089

Медицинская библиотека · BMJ case reports · 2022

VEXAS syndrome with progression of MDS to MDS/MPN overlap syndrome.

Neupane Karun, Jayarangaiah Apoorva, Zhang Yan, Kumar Abishek

Клинический случайСтатьяПеревод в очереди

Аннотация

VEXAS (vacuoles, E1 enzyme, X linked, autoinflammatory, somatic) syndrome is a novel inflammatory syndrome that was first described in December 2020. Patients with VEXAS syndrome have a somatic mutation in the UBA1 gene, inflammatory conditions and usually haematological conditions. Haematological conditions reported in patients with VEXAS syndrome include myelodysplastic syndrome (MDS), clonal cytopenia of undetermined significance, plasma cell neoplasm including multiple myeloma/monoclonal gammopathy of undetermined significance, haemophagocytic lymphohistiocytosis and monoclonal B-cell lymphocytosis. Here we describe a patient with VEXAS syndrome who had a progression of MDS to MDS/myeloproliferative neoplasm overlap syndrome. The ocular findings so far reported in these patients include episcleritis, uveitis, blepharitis and orbital cellulitis. Here we report retinal detachment as a clinical feature of VEXAS syndrome. This finding has a significant implication in patient management as it warrants higher vigilance for this sight-threatening complication.

Для цитирования: Neupane Karun, Jayarangaiah Apoorva, Zhang Yan, Kumar Abishek. VEXAS syndrome with progression of MDS to MDS/MPN overlap syndrome.. BMJ case reports. 2022. DOI: 10.1136/bcr-2022-251089.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.